Literature DB >> 16160911

Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.

Junbao Yang1, Laurel Huston, Deanna Berger, Nancy A Danke, Andrew W Liu, Mary L Disis, William W Kwok.   

Abstract

Human histocompatibility leukocyte antigen (HLA)-DPA1*0103/DPB1*0401 (DP0401) is the most common HLA class II molecule and is present in approximately 45% of the Caucasian population. In this study, soluble HLA-DP0401 molecules were expressed as "empty'' class II molecules in insect cells. Utilizing these soluble DP molecules and the Tetramer Guided Epitope Mapping (TGEM) approach, the influenza A Puerto Rico/8/34 matrix protein (MP) derived peptide MP(41-60) VLMEWLKTRPILSPLTKGIL and the Clostridium tetani Tetanus Toxin (TT) derived peptide TT(634-653) DKISDVSTIVPYIGPALNIV were identified as the DP0401 restricted MP and TT epitopes, respectively. In addition, T cells specific for the cancer testis antigen NY-ESO-1 and the breast/ovarian cancer over-expressing antigen Her-2/neu were detected in DP0401 subjects by DP0401 tetramers. The availability of HLA-DP0401 tetramers should facilitate the study of DP restricted T cell responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160911     DOI: 10.1007/s10875-005-6095-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.

Authors:  Gang Zeng; Yong Li; Mona El-Gamil; John Sidney; Alexandro Sette; Rong-fu Wang; Steven A Rosenberg; Paul F Robbins
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

2.  Autoreactive T cells in healthy individuals.

Authors:  Nancy A Danke; David M Koelle; Cassian Yee; Sucheta Beheray; William W Kwok
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 3.  Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.

Authors:  A P Fontenot; B L Kotzin
Journal:  Tissue Antigens       Date:  2003-12

4.  Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis.

Authors:  B L Kotzin; M T Falta; F Crawford; E F Rosloniec; J Bill; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP.

Authors:  F C Gilchrist; C Bunn; P J Foley; P A Lympany; C M Black; K I Welsh; R M du Bois
Journal:  Genes Immun       Date:  2001-04       Impact factor: 2.676

6.  Association between HLA-DPB1 matching and 1-year rejection-free graft survival in high-risk corneal transplantation.

Authors:  B Munkhbat; M Hagihara; T Sato; F Tsuchida; K Sato; J Shimazaki; K Tsubota; K Tsuji
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

7.  Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.

Authors:  Aude Bonehill; Carlo Heirman; Sandra Tuyaerts; Annelies Michiels; Yi Zhang; Pierre van der Bruggen; Kris Thielemans
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease.

Authors:  E Hermann; W J Mayet; H Thomssen; J Sieper; T Poralla; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Rheumatol       Date:  1992-08       Impact factor: 4.666

9.  Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.

Authors:  Gema Díaz; Massimo Amicosante; Dolores Jaraquemada; Richard H Butler; M Victoria Guillén; Miguel Sánchez; César Nombela; Javier Arroyo
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

10.  Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901.

Authors:  K Fleischhauer; E Zino; B Mazzi; E Sironi; P Servida; E Zappone; E Benazzi; C Bordignon
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

View more
  7 in total

Review 1.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

2.  Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.

Authors:  Ronit Mazor; Selamawit Addissie; Youjin Jang; Chin-Hsien Tai; Jeremy Rose; Fran Hakim; Ira Pastan
Journal:  AAPS J       Date:  2016-10-27       Impact factor: 4.009

3.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

4.  Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein.

Authors:  Li Chen; Damien Zanker; Kun Xiao; Chao Wu; Quanming Zou; Weisan Chen
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

5.  Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.

Authors:  Alexandra M Johansson; Uma Malhotra; Yeseul G Kim; Rebecca Gomez; Maxwell P Krist; Anna Wald; David M Koelle; William W Kwok
Journal:  PLoS Pathog       Date:  2021-12-29       Impact factor: 6.823

6.  HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.

Authors:  Claire Ventura; Hélène Bisceglia; Yves Girerd-Chambaz; Nicolas Burdin; Pascal Chaux
Journal:  J Clin Immunol       Date:  2012-07-15       Impact factor: 8.317

7.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.

Authors:  Sune Justesen; Mikkel Harndahl; Kasper Lamberth; Lise-Lotte B Nielsen; Søren Buus
Journal:  Immunome Res       Date:  2009-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.